Malaria epidemic in Burundi [13]

Lancet

Volumn 357, Issue 9261, 2001, Pages 1046-1047

  Etchegorry, M Gastellu ^a,b,c,d   Matthys, F ^a,b,c,d   Galinski, M ^a,b,c,d   White, N J ^a,b,c,d   Nosten, F ^e  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b MÉDECINS SANS FRONTIÈRES   (Belgium)

^c Malaria Foundation International   (United States)

^d MAHIDOL OXFORD TROPICAL MEDICINE RESEARCH UNIT   (Thailand)

^e SHOKLO MALARIA RESEARCH UNIT   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ARTESUNATE; CHLOROQUINE; FANSIDAR;

BURUNDI; DISEASE COURSE; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; EPIDEMIC; HEALTH CARE POLICY; HUMAN; LETTER; MALARIA; MEDICAL ETHICS; MONOTHERAPY; MORTALITY; MULTIDRUG RESISTANCE; PLASMODIUM FALCIPARUM; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLIC HEALTH SERVICE;

EID: 0035978075     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)71623-8     Document Type: Letter

References (5)

1. The efficacy of pyrimethamine-sulfadoxine (Fansidar) in the treatment of uncomplicated Plasmodium falciparum malaria in Kenya children
2. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector
3. Efficacy of artensunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: A double-bline, randomised, controlled trial
4. Oral artesunate in the treatment of uncomplicated hyperparasitemic falciparum malaria
5. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: A prospective study